Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Phase 2 Study of Enarodustat (JTZ-951) in Renal Anemia on Maintenance Hemodialysis
jRCT2080222207Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enarodustat in anemia of renal disease, anaemia and chronic kidney disease (CKD), sponsored by Japan Tobacco. Primary endpoints: Efficacy of enarodustat in correcting anemia and Safety of enarodustat. Started Sep 2013; status: completed.
02
Drugs
enarodustat
03
Conditions
anemia of renal diseaseanaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080222207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222207.